RBC Europe’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $588K | Hold |
6,181
| – | – | 0.03% | 132 |
|
|
2022
Q1 | $728K | Sell |
6,181
-20
| -0.3% | -$2.36K | 0.03% | 128 |
|
|
2021
Q4 | $803K | Buy |
6,201
+420
| +7% | +$54.4K | 0.04% | 123 |
|
|
2021
Q3 | $654K | Buy |
5,781
+60
| +1% | +$6.79K | 0.03% | 174 |
|
|
2021
Q2 | $593K | Buy |
5,721
+2,070
| +57% | +$214K | 0.03% | 187 |
|
|
2021
Q1 | $305K | Hold |
3,651
| – | – | 0.02% | 235 |
|
|
2020
Q4 | $333K | Hold |
3,651
| – | – | 0.02% | 215 |
|
|
2020
Q3 | $291K | Sell |
3,651
-300
| -8% | -$23.9K | 0.02% | 214 |
|
|
2020
Q2 | $273K | Buy |
3,951
+1,290
| +48% | +$89.2K | 0.02% | 212 |
|
|
2020
Q1 | $167K | Sell |
2,661
-270
| -9% | -$17K | 0.02% | 232 |
|
|
2019
Q4 | $228K | Hold |
2,931
| – | – | 0.02% | 235 |
|
|
2019
Q3 | $215K | Sell |
2,931
-210
| -7% | -$15.4K | 0.02% | 238 |
|
|
2019
Q2 | $193K | Buy |
3,141
+225
| +8% | +$13.9K | 0.02% | 250 |
|
|
2019
Q1 | $186K | Sell |
2,916
-318
| -10% | -$20.3K | 0.02% | 245 |
|
|
2018
Q4 | $165K | Hold |
3,234
| – | – | 0.02% | 243 |
|
|
2018
Q3 | $188K | Hold |
3,234
| – | – | 0.02% | 257 |
|
|
2018
Q2 | $157K | Hold |
3,234
| – | – | 0.02% | 285 |
|
|
2018
Q1 | $150K | Hold |
3,234
| – | – | 0.02% | 277 |
|
|
2017
Q4 | $122K | Hold |
3,234
| – | – | 0.02% | 325 |
|
|
2017
Q3 | $118K | Buy |
+3,234
| New | +$118K | 0.02% | 328 |
|